BACHEM N -B- | 366,50 / +0,41% |
Data / Laikas | 22.01. / 17:30 |
Pok. / Pok.(%) | 1,50 / +0,41% |
Bid | 363,50 / 170 |
Ask | 369,00 / 300 |
Atidaryti | 362,00 |
Ankstesnį uždaryti | 365,00 |
Aukšč. | 367,50 |
Žem. | 361,50 |
APYVARTA [CHF] | 4.641.594,75 |
APYVARTA [Units] | 12.741 |
Price fixings | 801 |
ISIN | CH0012530207 |
Simbolis | BANB |
Birža | SIX Swiss Exchange |
Rūšis | Stock |
Visos biržos
Birža | Paskutinis | APYVARTA | |
---|---|---|---|
Lang & Schwa.. | 333,50 | ![]() |
|
SIX Swiss Ex.. | 366,50 | ![]() |
12.741 |
London Inter.. | 367,50 | ![]() |
152 |
Nasdaq Other.. | 418,0000 | 48 | |
Frankfurt | 115,0000 | 0 | |
Berlin | 116,20 | 0 | |
München | 114,80 | 0 | |
Hamburg | 114,80 | 0 | |
EUREX | Options |
Naujienos
- Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome
14.05.2020 / 07:00 - GlobeNewswire - Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
04.05.2020 / 14:30 - GlobeNewswire - Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
28.04.2020 / 15:24 - GlobeNewswire - Vaccine Contract Manufacturing Market, 2030 - Market is Anticipated to Generate Revenues Worth USD 100 Billion by 2025
04.10.2019 / 10:05 - GlobeNewswire - Global Pharmaceutical Contract Manufacturing Market 2018-2025 - Patent Expiration Of Small Molecules Drugs & Advanced Technologies In API And FDF Manufacturing
26.03.2019 / 10:57 - GlobeNewswire